Our Immuno-oncology research program aims to treat most human cancers with immune therapy.
Our Oncology group explores mechanisms and potential therapeutics for a wide range of both common and rare cancers.
Learn how our recent advances in model systems and technology help us pursue revolutionary therapies for neurodegenerative, neurodevelopmental and neuropsychiatric conditions.
Concentrates on dyslipidemia, atherosclerosis and vascular diseases, type 2 diabetes, heart failure, cardiac arrhythmias and associated disorders.
Pioneers novel therapeutic modalities for the treatment of rheumatic and dermatological diseases as well as other auto-immune and inflammatory conditions.
Investigates both viral infections, such as the hepatitis B virus, respiratory syncytial virus, and human cytomegalovirus, as well as on bacterial pathogens, such as Clostridium difficile, Staphylococcus aureus, and Pseudomonas aeruginosa.
Researches muscle wasting associated with disuse due to cancer, chronic obstructive pulmonary disease, and aging, as well as andosteoporosis.
The ophthalmology team at NIBR is working on new scientific discoveries for eye disorders including age-related macular degeneration.
Concentrates on cystic fibrosis, idiopathic pulmonary fibrosis, pulmonary arterial hypertension, chronic obstructive pulmonary disease and asthma.
This site is intended for a global audience.